PMAM
COLL icon

Picton Mahoney Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Picton Mahoney Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31
Closed -$1.02K – 1437
2026
Q1 		$1.02K Hold
31
– – ﹤0.01% 1151
2025
Q4 		$1.44K Hold
31
– – ﹤0.01% 1015
2025
Q3 		$1K Hold
31
– – ﹤0.01% 899
2025
Q2 		$1K Hold
31
– – ﹤0.01% 777
2025
Q1 		$1K Hold
31
– – ﹤0.01% 751
2024
Q4 		$1K Hold
31
– – ﹤0.01% 645
2024
Q3 		$1K Buy
+31
New +$1.11K ﹤0.01% 636

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Picton Mahoney Asset Management's COLL Position: Q2 2026 in Review

Picton Mahoney Asset Management sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 31 shares — an estimated $1.02K sold.

Picton Mahoney Asset Management first reported a position in COLL in Q3 2024 and held it in 7 quarters. The position peaked at $1.44K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Picton Mahoney Asset Management reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 31 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.02K.
  • Picton Mahoney Asset Management first reported a position in Collegium Pharmaceutical in Q3 2024 and held it in 7 quarters.
  • Picton Mahoney Asset Management's Collegium Pharmaceutical position peaked at $1.44K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.